Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Total Non-Current Liabilities: 2022-2025

Historic Total Non-Current Liabilities for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $172,539.

  • Addex Therapeutics' Total Non-Current Liabilities rose 51.63% to $172,539 in Q2 2025 from the same period last year, while for Jun 2025 it was $172,539, marking a year-over-year increase of 51.63%. This contributed to the annual value of $226,134 for FY2024, which is 66.33% down from last year.
  • Per Addex Therapeutics' latest filing, its Total Non-Current Liabilities stood at $172,539 for Q2 2025, which was up 17.37% from $146,999 recorded in Q1 2025.
  • In the past 5 years, Addex Therapeutics' Total Non-Current Liabilities ranged from a high of $815,919 in Q1 2022 and a low of $39,281 during Q1 2023.
  • In the last 3 years, Addex Therapeutics' Total Non-Current Liabilities had a median value of $174,408 in 2023 and averaged $216,788.
  • Examining YoY changes over the last 5 years, Addex Therapeutics' Total Non-Current Liabilities showed a top increase of 652.68% in 2023 and a maximum decrease of 95.19% in 2023.
  • Over the past 4 years, Addex Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $90,337 in 2022, then soared by 652.68% to $679,948 in 2023, then tumbled by 66.60% to $227,093 in 2024, then surged by 51.63% to $172,539 in 2025.
  • Its Total Non-Current Liabilities stands at $172,539 for Q2 2025, versus $146,999 for Q1 2025 and $227,093 for Q4 2024.